Filtros de búsqueda

Lista de obras de

A Risk Assessment Tool Incorporating New Biomarkers for Cardiovascular Events in Acute Coronary Syndromes: The Organization to Assess Strategies in Ischemic Syndromes (OASIS) Risk Score

artículo científico publicado en 2016

ACE inhibition in stable coronary artery disease

artículo científico publicado en 2005

Aliskiren alone or with other antihypertensives in the elderly with borderline and stage 1 hypertension: the APOLLO trial.

artículo científico publicado en 2014

Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials

artículo científico publicado en 2006

Aspirin in patients undergoing noncardiac surgery

artículo científico publicado en 2014

Basal insulin and cardiovascular and other outcomes in dysglycemia

artículo científico publicado en 2012

Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range

artículo científico publicado en 2008

Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease

artículo científico publicado en 2016

Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease

artículo científico publicado en 2016

Canadian-led capacity-building in biostatistics and methodology in cardiovascular and diabetes trials: the CANNeCTIN Biostatistics and Methodological Innovation Working Group

artículo científico publicado en 2011

Cardiovascular risk in patients with early renal insufficiency: implications for the use of ACE inhibitors

artículo científico publicado en 2002

Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non-inferiority, randomised controlled trial (SIMPLE).

artículo científico publicado en 2015

Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study

artículo científico publicado en 2013

Challenges of establishing new antithrombotic therapies in atrial fibrillation

artículo científico publicado en 2007

Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease

artículo científico publicado en 2016

Clinician-trialist rounds: 19. Faux pas or fraud? Identifying centers that have fabricated their data in your multi-center trial

artículo científico publicado en 2013

Clinician-trialist rounds: 23. When an RCT's Data Center Report drowns vital information in seas of data: where's Waldo?

artículo científico publicado en 2014

Clonidine in patients undergoing noncardiac surgery

artículo científico

Cognitive function and anticoagulation control in patients with atrial fibrillation

artículo científico publicado en 2010

Community health worker-based intervention for adherence to drugs and lifestyle change after acute coronary syndrome: a multicentre, open, randomised controlled trial

artículo científico publicado en 2016

Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study

artículo científico publicado en 2006

Comparison of fondaparinux and enoxaparin in acute coronary syndromes

artículo científico publicado en 2006

Cost implications of the use of ramipril in high-risk patients based on the Heart Outcomes Prevention Evaluation (HOPE) study

artículo científico publicado en 2003

Dabigatran and warfarin in vitamin K antagonist-naive and -experienced cohorts with atrial fibrillation

artículo científico publicado en 2010

Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial

artículo científico publicado en 2018

Dabigatran versus warfarin in patients with atrial fibrillation

artículo científico publicado en 2009

Designing and analyzing clinical trials with composite outcomes: consideration of possible treatment differences between the individual outcomes

artículo científico publicado en 2012

Direct-acting oral anticoagulants: the brain gets a break

artículo científico publicado en 2013

Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes ⬇️

artículo científico publicado el 2 de septiembre de 2010

Effect of angiotensin-converting enzyme inhibition on functional class in patients with left ventricular systolic dysfunction--a meta-analysis

artículo científico publicado en 2005

Effect of clopidogrel added to aspirin in patients with atrial fibrillation

artículo científico publicado en 2009

Effect of comorbidities on outcomes and angiotensin converting enzyme inhibitor effects in patients with predominantly left ventricular dysfunction and heart failure

artículo científico publicado en 2014

Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial

artículo científico publicado en 2005

Effect of long-term ACE-inhibitor therapy in elderly vascular disease patients

artículo científico publicado en 2007

Effect of ramipril in reducing sudden deaths and nonfatal cardiac arrests in high-risk individuals without heart failure or left ventricular dysfunction

artículo científico publicado en 2004

Effect of ramipril on the incidence of diabetes

artículo científico publicado en 2006

Effect of telmisartan on renal outcomes: a randomized trial.

artículo científico publicado en 2009

Effects of aspirin dose on ischaemic events and bleeding after percutaneous coronary intervention: insights from the PCI-CURE study

artículo científico publicado en 2008

Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial

artículo científico publicado en 2008

Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial

artículo científico

Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: a systematic review

artículo científico publicado en 2002

Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial

artículo científico publicado en 2005

Effects of off-pump and on-pump coronary-artery bypass grafting at 1 year

artículo científico publicado en 2013

Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy

artículo científico publicado en 2002

Effects of vitamin E on cardiovascular outcomes in people with mild-to-moderate renal insufficiency: results of the HOPE study

artículo científico publicado en 2004

Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial

artículo científico publicado en 2010

Evaluating the benefit of event adjudication of cardiovascular outcomes in large simple RCTs

artículo científico publicado en 2009

Extracranial Systemic Embolic Events in Patients With Nonvalvular Atrial Fibrillation: Incidence, Risk Factors, and Outcomes

artículo científico publicado en 2015

Fondaparinux with UnfracTionated heparin dUring Revascularization in Acute coronary syndromes (FUTURA/OASIS 8): a randomized trial of intravenous unfractionated heparin during percutaneous coronary intervention in patients with non-ST-segment elevat

artículo científico publicado en 2010

Homocysteine lowering with folic acid and B vitamins in vascular disease

artículo científico publicado en 2006

Identifying Novel Biomarkers for Cardiovascular Events or Death in People With Dysglycemia

artículo científico

Impact of ramipril on the circadian periodicity of acute myocardial infarction

artículo científico publicado en 2006

Impact of ramipril on the incidence of atrial fibrillation: results of the Heart Outcomes Prevention Evaluation study.

artículo científico publicado en 2007

Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy

artículo científico publicado en 2007

Irbesartan in Patients with Atrial Fibrillation ⬇️

artículo científico publicado el 10 de marzo de 2011

Long-term effects of ramipril on cardiovascular events and on diabetes: results of the HOPE study extension

artículo científico publicado en 2005

Long-term evaluation of dabigatran 150 vs. 110 mg twice a day in patients with non-valvular atrial fibrillation

artículo científico publicado en 2016

Low-dose vs standard-dose unfractionated heparin for percutaneous coronary intervention in acute coronary syndromes treated with fondaparinux: the FUTURA/OASIS-8 randomized trial

artículo científico

Methylprednisolone in patients undergoing cardiopulmonary bypass (SIRS): a randomised, double-blind, placebo-controlled trial

artículo científico publicado en 2015

Modifiable lifestyle and social factors affect chronic kidney disease in high-risk individuals with type 2 diabetes mellitus

artículo científico publicado en 2014

Mortality predictors and effects of antithrombotic therapies in atrial fibrillation: insights from ACTIVE-W.

artículo científico publicado en 2010

Nitrous oxide and serious morbidity and mortality in the POISE trial

artículo científico publicado en 2013

Novel Approaches in Primary Cardiovascular Disease Prevention: The HOPE-3 Trial Rationale, Design, and Participants' Baseline Characteristics

artículo científico publicado en 2015

Oral anticoagulant and antiplatelet therapy and peripheral arterial disease

artículo científico publicado en 2007

Predictors, Prognosis, and Management of New Clinically Important Atrial Fibrillation After Noncardiac Surgery: A Prospective Cohort Study

artículo científico publicado en 2017

Prednisolone and Mycobacterium indicus pranii in tuberculous pericarditis

artículo científico publicado en 2014

Prevention of Heart Failure in Patients in the Heart Outcomes Prevention Evaluation (HOPE) Study

artículo científico publicado en 2003

Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease

artículo científico publicado en 2005

Prognostic usefulness of left ventricular hypertrophy by electrocardiography in patients with atrial fibrillation (from the Randomized Evaluation of Long-Term Anticoagulant Therapy Study).

artículo científico publicado en 2013

Prognostic utility and characterization of cell-free DNA in patients with severe sepsis

artículo científico publicado en 2012

Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study

artículo científico publicado en 2009

Prospective long-term evaluation of Optim-insulated (Riata ST Optim and Durata) implantable cardioverter-defibrillator leads

artículo científico publicado en 2014

Randomized Trial of Benznidazole for Chronic Chagas' Cardiomyopathy

artículo científico publicado en 2015

Randomized trial of primary PCI with or without routine manual thrombectomy

artículo científico publicado en 2015

Rationale and design of AVERROES: apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment

artículo científico publicado en 2010

Rationale and design of the Investigation of the Management of Pericarditis (IMPI) trial: a 2 × 2 factorial randomized double-blind multicenter trial of adjunctive prednisolone and Mycobacterium w immunotherapy in tuberculous pericarditis

artículo científico publicado en 2012

Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial

artículo científico publicado en 2004

Reevaluation by high-performance liquid chromatography: clinical significance of microalbuminuria in individuals at high risk of cardiovascular disease in the Heart Outcomes Prevention Evaluation (HOPE) Study

artículo científico publicado en 2006

Referrals in Acute Coronary Events for CARdiac Catheterization: The RACE CAR trial ⬇️

artículo científico publicado el 1 de octubre de 2010

Relationship of activated partial thromboplastin time to coronary events and bleeding in patients with acute coronary syndromes who receive heparin

artículo científico publicado en 2003

Relationship of anti-60 kDa heat shock protein and anti-cholesterol antibodies to cardiovascular events

artículo científico publicado en 2002

Relationship of electrocardiographic left ventricular hypertrophy to mortality and cardiovascular morbidity in high-risk patients

artículo científico publicado en 2003

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.

artículo científico publicado en 2008

Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies

artículo científico publicado en 2010

Response to Letter Regarding Article, “Challenges of Establishing New Antithrombotic Therapies in Atrial Fibrillation”

Response to letter regarding article, "Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study"

artículo científico publicado en 2014

Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE-W).

artículo científico publicado en 2008

Statistical Approaches to Improving Trial Efficiency and Conduct

Steroids In caRdiac Surgery (SIRS) trial: acute kidney injury substudy protocol of an international randomised controlled trial

artículo científico publicado en 2014

Systolic and diastolic blood pressure changes in relation with myocardial infarction and stroke in patients with coronary artery disease

artículo científico

Telmisartan in high-risk patients intolerant of ACE inhibitors – Authors' reply

artículo científico publicado en 2009

Telmisartan, ramipril, or both in patients at high risk for vascular events

artículo científico publicado en 2008

Testing for heterogeneity among the components of a binary composite outcome in a clinical trial

artículo científico publicado en 2010

The Effect of Vitamin E Supplementation on Cardiovascular Risk in Diabetic Individuals With Different Haptoglobin Phenotypes

artículo científico publicado en 2004

The Family Atherosclerosis Monitoring In earLY life (FAMILY) study: rationale, design, and baseline data of a study examining the early determinants of atherosclerosis

artículo científico publicado en 2009

The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study

artículo científico publicado en 2013

The need to test the theories behind the Polypill: rationale behind the Indian Polycap Study

artículo científico publicado en 2008

The statistical significance of randomized controlled trial results is frequently fragile: a case for a Fragility Index

artículo científico publicado en 2014

Two-year outcomes in patients admitted with non-ST elevation acute coronary syndrome: results of the OASIS registry 1 and 2.

artículo científico publicado en 2005

Use of ramipril in preventing stroke: double blind randomised trial

artículo científico publicado en 2002

Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies

artículo científico publicado en 2007

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda